Why is Kobo Biotech falling/rising?

As of 18-Sep, Kobo Biotech Ltd's stock price is currently at Rs 2.18, reflecting a decline of Rs 0.09 or 3.96%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 6.03% during this period. It is also trading below all key moving averages, indicating a bearish trend. In terms of performance against the benchmark, the stock has shown a significant decline of 25.34% over the past year, while the Sensex has only increased by 0.08%. Additionally, the stock is close to its 52-week low, being just 3.67% away from Rs 2.1. There is a slight positive note with rising investor participation, as the delivery volume increased by 46.71% compared to the 5-day average, but this has not been enough to counteract the overall downward trend.
Broader Market Context: In the short term, Kobo Biotech's stock has underperformed the Sensex, which has gained 1.80% over the past week while Kobo Biotech has declined by 3.11%. This stark contrast highlights the stock's struggles relative to the broader market. The overall market sentiment appears to be more favorable, as indicated by the Sensex's positive returns over various periods, while Kobo Biotech continues to face significant challenges, as evidenced by its substantial losses over the past three and five years. The lack of available positive factors further emphasizes the difficulties the company is experiencing in the current market environment.